Force transmission at the myotendinous junction requires a strong link between the muscle cytoskeleton and the extracellular matrix. At the adult junction, two splice variants of the laminin-binding integrins, a7Ab1D and a7Bb1D, are highly enriched. The a7 subunits are critical for the integrity of the junctional sarcolemma because integrin a7-deficient mice develop muscular dystrophy, primarily affecting this site of the muscle. Here, we report that b1D integrin coimmunoprecipitates and colocalizes with the a5 subunit at a7-deficient junctions, but does not associate with a3, a6 or av integrins. By immunogold labelling we show that the basement membranes of integrin a7-deficient muscles recruit abnormally high levels of fibronectin, the ligand of a5b1D. Finally, we demonstrate that a5b1D is down-regulated at the normal postnatal junction and is displaced by a7b1D. These results suggest that the a7 subunit is implicated in the down-regulation of a5b1D and in the removal of fibronectin from the maturing myotendinous junction, thus providing an a7b1D-based link to laminin. We propose that the persistence of a5b1D in a7-deficient mice is not compatible with normal muscle function and leads to muscle wasting.
INTRODUCTION
The transduction of force from the muscle fibre to the tendon is a prerequisite for vertebrate motility. It takes place at the myotendinous junction (MTJ), a highly specialized structure at which the sarcolemma interdigitates with the tendon. This arrangement enlarges the interface between muscle and tendon and decreases the force placed on any one area of the terminating myofibre (1) (2) (3) . A thin muscle basement membrane covers the interdigitations and provides an anchor for the collagen fibres of the tendon.
The molecular composition of the MTJ is not well understood. Two transmembrane receptors are known to be enriched at this site, namely the dystrophin-associated protein complex (DPC) (4) and a7b1 integrin (5) . The DPC binds to dystrophin and laminin, thereby forming a link between the cytoskeleton and the basement membrane (6, 7) . Mutations in the dystrophin gene cause Duchenne and Becker muscular dystrophies (8) , while the genes encoding components of the DPC are mutated in some limb girdle muscular dystrophies (9) . Owing to their lack of dystrophin (10), mdx mice serve as a model for the study of many aspects of muscle wasting. At mdx MTJs, there are elevated levels of dystrophin-related and associated proteins (11) and a reduction of membrane folds. The latter alteration is chiefly detected at the onset of the disease (12) .
Integrins are heterodimeric transmembrane proteins of non-covalently linked a and b subunits. They are important for diverse cellular functions such as migration, differentiation, tissue repair or programmed cell death (13, 14) . Among the b integrins, the b1 chain is ubiquitously expressed. Its carboxy-terminal splice variant, b1D, is detected only in skeletal and cardiac muscles (15) (16) (17) , where it is concentrated at the MTJs, costamers and intercalated discs (17, 18) . Upon heterologous expression, b1D is targeted into focal contact sites (17) . In b1-deficient cells, b1D causes multiple changes in the cell morphology and strengthens the link between the cytoskeleton and the extracellular matrix (19) . Although b1D has been implicated in myogenesis (20) , mice depleted of the b1D-encoding exon have no apparent skeletal muscle phenotype; yet they show a mild disturbance of cardiac function (21) . The b1A and b1D variants are not functionally equivalent since mice expressing b1D instead of b1A in all tissues die during development. On the other hand, the targeted mutation of the b1D exon seems to be compensated by b1A (21) . Clearly, b1D integrin has an important, but perhaps not essential, function at the MTJ.
b1D associates with several a subunits in the heart (17, 22) . In skeletal muscle, it binds exclusively to the laminin-binding a7 chain (17, 18, 23, 24) . There are four major splice variants of a7; two (X1 and X2) are found in the extracellular region of the protein and two (A and B) in the cytoplasmic tail (25, 26) . In addition, there are less abundant variants of the extracellular part (27, 28) . All four major variants are present during muscle development, but adult muscles express only X2 and not X1 (29, 26) . The a7A and a7B chains are located at the sarcolemma and also at the neuromuscular junction (30) , where a7 has been implicated in the clustering of acetylcholine receptors (31, 32) .
The a7A and a7B chains are highly enriched at the MTJ where no other a subunits have been detected so far (5) . The exact function of integrin a7 at this site is not known. We have previously shown that mice carrying a targeted deletion of their a7 gene (Itga7) develop muscular dystrophy primarily affecting muscle fibres in the vicinity of the MTJ (33) . The first signs of abnormal MTJs are detectable around 3 weeks after birth. At adult junctions, the numbers of interdigitations are dramatically reduced and myofilaments appear retracted from the sarcolemma (33, 34) . Moreover, the muscle basement membranes are widened and do not contain the laminin a2 chain, which is instead accumulated in the matrix of the tendon (34) . Recently, patients suffering from muscular dystrophy/congenital myopathy have been shown to carry mutations in their ITGA7 gene (35, 36) . All this evidence suggests that the a7 and b1D subunits are important components of the MTJ, as they provide a critical link between the junctional cytoskeleton and the extracellular matrix.
In this study, we sought to identify molecular abnormalities preceding the onset of muscle wasting in a7-deficient mice in order to discern the function of integrin a7 in muscle. We show that b1D is retained at mutant MTJs and specifically binds to the a5 chain, but not to a3, a6 or av-containing integrins. Concomitantly fibronectin, the ligand of a5b1, is amply deposited into the basement membranes of mutant muscles. Finally, we show that a5b1D is down-regulated at the postnatal MTJs of normal or mdx muscles, but not of a7-deficient ones. Our data suggest that the a7 subunit plays an important role in the maturation of the MTJ, that it provides a link to laminin, and that it is involved in displacing a5b1D and fibronectin from this site. The persistence of a5b1D and fibronectin at a7-deficient MTJs is a molecular defect that may result in an inferior anchorage of the muscle cytoskeleton and may ultimately lead to muscle wasting.
RESULTS

Integrin a7-deficient muscles are morphologically abnormal
Integrin a7-deficient muscles display a dystrophic phenotype only in the vicinity of their MTJs, as we have described on the ultrastructural level (33, 34) and is shown by light microscopy in Figure 1A and B. To determine whether mutant muscle fibres showed additional defects indiscernible by histological analysis, we established primary interosseus muscle cultures and examined the fibre morphology. Wild-type fibres (Fig. 1C ) were multi-nucleated, cross-striated, and had smooth ends. Fibres derived from mdx mice looked very similar to wild-type ones ( Fig. 1E ). By contrast, a7-deficient fibres displayed an altered morphology, their ends being deformed and enlarged and containing vacuoles ( Fig. 1D and F). Quantification of this phenotype revealed that, while control cultures contained mostly normal-looking fibres (108/111 and 96/101; Fig. 1C ), about half of the a7 mutant fibres (98/194 and 107/200) had small vacuoles and dented ends ( Fig. 1D ). One third (61/ 194 and 73/200) displayed large vacuoles and ends with twice the normal diameter ( Fig. 1F ). The remaining a7-deficient fibres (35/194 and 20/200 ) looked similar to the controls. Notably, despite the absence of a7 integrin and the severe damage at their ends, mutant fibres were multi-nucleated and cross-striated. Therefore, a7-deficiency impairs neither myoblast fusion nor the organization of sarcomeres but rather affects the integrity of the ends of differentiated myofibres. These end regions are equivalent to the MTJs in skeletal muscles.
b1D integrin is retained at a7-deficient MTJs and associates with the a5 chain
The molecular mechanisms underpinning integrin a7-deficient muscular dystrophy are not understood. Since a7 binds specifically to b1D integrin at normal MTJs, we expected b1D to be lost from a7-depleted muscles as well. However, immunofluorescence staining revealed that the level of b1D expression at mutant junctions was similar to those of control MTJs. b1D's extrajunctional distribution was, however, greatly reduced ( Fig. 2) . These results implied that b1D associates with a different a integrin in a7-deficient muscles. Strong candidates were a3 and a6 because of their high sequence similarity to a7 (26), a5 due to its regulated expression during myogenesis (37) , and av because av is enriched at MTJ-like regions during development (38) .
To test these candidates for interaction with b1D, we generated specific antisera and performed coimmunoprecipitation and immunoblotting studies. As expected, a7A and a7B precipitated together with b1D from wild-type but not from mutant muscle extracts ( Fig. 3A ). On immunoblots of whole muscle extracts or b1D immunoprecipitates, we observed pairs of b1D-reactive bands (Fig. 3A) , of which the low molecular weight form corresponded to the incompletely glycosylated b1D chain (18) . Notably, this low molecular weight form did not dimerize a7 integrin. Moreover, the relative intensity of this band was increased in mutant muscles ( Fig. 3A ), suggesting that glycosylation of b1D integrin is less efficient in a7-deficient muscles. As shown in Figure 3B , the a3 chain was not detected in adult wild-type or mutant muscle, whereas immunoprecipitation clearly showed the presence of a6 integrin in these muscles. However, a6 did not coimmunoprecipitate with b1D ( Fig. 3B ). The av chain was detected by immunoprecipitation in postnatal day 2 (P2) but not in adult muscles. Yet, av also failed to be coimmunoprecipitated with b1D, nor was there av immunostaining at mutant MTJs ( Fig. 3C , and data not shown).
As opposed to the other a subunits, a5 coimmunoprecipitated with b1D from mutant muscles, but not from wild-type ones ( Fig. 4 ). On a5 immunoblots, the b1D-precipitated signals were equally strong when RIPA extracts were derived from pooled TA or pooled soleus muscles. These results show that b1D associates specifically with a5 integrin in a7-deficient muscles, but not with the a3, a6 or av subunits.
The a5 and b1D integrin subunits colocalize in a7-deficient muscles
To corroborate that a5b1D integrin was indeed expressed at a7-deficient MTJs, we performed colocalization studies. As anticipated, there was no overlapping distribution of a5 and b1D in adult wild-type muscles ( Fig. 5 ). a5 was confined to Figure 1 . Deformed apical regions of integrin a7-deficient myofibres. Hematoxylin and eosin staining of cryosections prepared from adult wild-type (A) and a7-deficient (B) TA muscles. Note that in the region near the tendon (arrows), mutant muscles displayed varying muscle fibre diameters, centralized nuclei and lymphocyte infiltrations. Asterisks mark two necrotic fibers. (C-F) phase contrast images of cultured myofibres isolated from wild-type (C), mdx (E), and a7-deficient (D and F) interosseus muscles. All fibres (C-F) were multinucleated and showed cross-striation. The distal regions of wild-type and mdx fibres (C, E) were round-shaped, whereas the majority of a7-deficient fibres showed uneven ends (D), or such that were grossly enlarged and deformed (F). Bars, 50 mm (A, B); 100 mm (C-F).
connective tissue and the endothelium, while b1D was strongly detected at the MTJs and at the sarcolemma of the soleus. By contrast, mutant MTJs displayed clear colocalization of both immunoreactivities ( Fig. 5 ). Some a5 signals did not colocalize with b1D, mostly in fibrotic areas of the muscle and probably resulting from a5b1A receptors expressed in fibroblasts. In mutant soleus, the distribution of b1D and a5 was discontinuous, a pattern that was not detected in the TA ( Fig. 5 ). All immunofluorescence results were confirmed by confocal laser microscopy (data not shown). Taken together, our double-labelling and coimmunoprecipitation results indicate that a5b1D integrin is expressed in place of a7b1D at a7-deficient MTJs.
a5b1D integrin is down-regulated from wild-type postnatal muscles
To address the question why a5b1D was retained at mutant MTJs, we analysed whether the a5 or a7 subunits heterodimerized with b1D during normal muscle maturation. Doubleimmunofluorescence and coimmunoprecipitation studies revealed that P2 and P5 muscles coexpressed the a5b1D and a7b1D integrins both at the MTJs and at the extrajunctional sarcolemma ( Fig. 6A and B) . On a5 and a7 immunoblots, there were also bands in the b1A-precipitated lanes (Fig. 6B ). These bands probably resulted from a5b1A being expressed in fibroblasts and endothelial cells, and from a7b1A being present in smooth muscle cells.
By P10, a5 immunostaining was found in endothelial cells and was barely detected at the MTJs or the sarcolemma. The a7 and b1D chains colocalized with each other, most prominently at the MTJs (Fig. 6A) . Coimmunoprecipitation experiments confirmed that most of a5 was associated with b1A and little with b1D, while b1D dimerized with both a7A and a7B ( Fig. 6B , and data not shown). On the other hand, mutant P10 MTJs showed strong colocalization of a5 and b1D (Fig. 6A) , and both subunits coimmunoprecipitated from mutant P10 extracts as they did in the adults (Fig. 6B , see also Fig. 4 ). These data indicate that, after an initial coexpression of a5b1D and a7b1D in early postnatal muscles, the a7b1D receptor is preserved at the maturing MTJ whereas a5b1D becomes downregulated. This down-regulation of a5b1D does not occur at integrin a7-deficient MTJs.
On northern blots, the levels of a5 messenger RNA declined dramatically by 3 weeks after birth, irrespective of whether RNA was prepared from normal or from integrin a7-depleted muscles (data not shown). Thus, a transcriptional up-regulation of a5 at mutant MTJs was unlikely. On immunoblots of P2 and P10 hind-limb muscle extracts, the a5 chain was detected with similar intensities, regardless of the animals' genotype ( Fig. 7 ; upper panel). In adult tissues, a5 was no longer found in the wild-types but was still detected in knock-out muscles. Figure 2 . Localization of b1D integrin in normal and a7 À/À muscles. Serial cryosections of TA muscles were stained with peptide antibodies against a7B and b1D. In the wild-types, a7B and b1D immunoreactivities were concentrated at the MTJs (arrows indicate tendons). Weaker staining was detected at the circumference of the muscle fibres. In a7-deficient muscles (right), b1D immunoreactivity was retained at the MTJs. Bar, 50 mm.
The strong band detected in the mutant soleus reflected the presence of a5 in muscle fibres and fibrotic tissue (33) . On nonreducing immunoblots, b1D was found at similar levels in all extracts (data not shown). Under reducing conditions, the incompletely glycosylated form of b1D was more abundant in the knock-outs than in the wild-types (Fig. 7, bottom panel) , confirming the coimmunoprecipitation data reported above. Altogether, these results demonstrate that the loss of a7 integrin Figure 3 . Association of integrin b1D with a7A and a7B in normal skeletal muscle. Protein extracts prepared from adult wild-type or a7-deficient TA muscles were immunoprecipitated with the specific antibodies indicated on the top of the panels, followed by immunoblotting as indicated on the right. (A) Under reducing conditions, the antibody directed against b1D immunoprecipitated a high molecular weight and a low molecular weight-band. The latter band was more prominent in mutant muscles. In the wild-types, b1D coimmunoprecipitated with a7B and a7A. Note that only the high molecular weight-form of b1D was coprecipitated with the a7 antibodies. (B) a3 integrin was not detected in muscle precipitates, while the a6 chain was immunoprecipitated by anti-a6 but not the b1D antibody. (C) the av subunit was absent from adult muscle extracts, although it could be precipitated from P2 muscles. The antibody specificity was demonstrated by loading 20 mg of protein extracts (c) prepared from skeletal muscle (b1D, a7A and a7B) or lung (a3, a6 and av).
disrupts the post-transcriptional down-regulation of a5b1D at the postnatal MTJ.
Fibronectin is recruited to basement membranes of a7-deficient muscles As a receptor exclusively for fibronectin, a5b1D might, aberrantly, recruit this ligand to the basement membranes of a7-deficient muscles. To distinguish fibronectin signals at the muscle from those at the adjacent fibrotic tissue, we performed immunogold-histochemistry. As predicted from our immunofluorescence data, wild-type MTJs displayed few a5-reactive signals, but showed instead strong a7B and b1D labelling at the plasma membrane ( Fig. 8A and B , and data not shown). At a7-deficient MTJs, a5 and b1D-labeled gold particles were detected at the plasma membrane and, in the case of b1D, abundantly inside the cells ( Fig. 8A and B) . These intracellular gold particles possibly reflected the incompletely glycosylated b1D form (see Figs 3, 4 and 7) that fails to be integrated into the plasma membrane.
On wild-type sections, fibronectin was detected in the connective tissue of the tendon but barely detected in the muscle basement membrane (Fig. 8C) . By contrast, a7-deficient MTJs displayed ample fibronectin signals in the basement membrane of the muscle fibre ( Fig. 8D ), in addition to an overall increased labelling of the tendon. Quantification of gold particles revealed a 2 to 3-fold amount of label in a7-deficient mice as in controls both in the basement membrane of the MTJ (13:5) and the tendon (65:31), while no differences were noted in the basement membrane (2:3) or the endomysium (17:18) at the lateral side of the muscle fibres. Thus, concomitant with the persistence of a5b1D at a7-deficient MTJs, there is a dramatically increased deposition of fibronectin at the muscle basement membrane.
a5b1D integrin does not persist at dystrophin-deficient MTJs Finally, we determined whether a5b1D also persisted at dystrophin-deficient MTJs. The dystrophic changes in adult mdx muscles were confirmed by conventional histology and by strong anti-fibronectin labelling indicating fibrosis (data not shown). On cryosections (Fig. 9A) , a5 immunoreactivity was amply detected in the connective tissue of the tendon and in the endomysium near the tendon. However, there was little or no colocalization of a5 and b1D (Fig. 9A) . Moreover, using extracts prepared from mdx TA muscles, b1D did not coimmunoprecipitate with the a5 chain but was associated with a7 integrin, as it is in the wild-types (Fig. 9B) . Therefore, the persistence of a5b1D integrin is not a phenotype of dystrophin-deficient muscles, but is instead a molecular change resulting from integrin a7 deficiency.
DISCUSSION
In this paper, we provide evidence that the maturation of the postnatal MTJ critically depends on a7b1D integrin. At wild-type MTJs, a7b1D displaces the coexpressed a5b1D integrin by 2 weeks after birth. This switch does not occur in a7-deficient muscles, but instead a5b1D persists into adulthood, and fibronectin accumulates in place of laminin at the junctional basement membrane of the muscle fibre. We propose that this a5b1D/fibronectin link is inferior to the a7b1D/ laminin link at the normal MTJ, and that this gain-of-function phenotype is a molecular abnormality preceding the onset of muscle wasting in a7-deficient mice.
Intact muscle fibres isolated from a7-deficient mice display grossly deformed ends; at the same time they are cross-striated and properly attached to the culture dish. These results confirm the observation that myoblast fusion and myofibrillogenesis proceed independently of laminin-binding integrin chains (33, 39) , and support our previous conclusion that a7b1 is critical for the integrity of the junctional but not the lateral regions of the muscle (33, 34) . At the lateral sarcolemma, a-dystroglycan of the DPC is known to link laminin with dystrophin and other cytoskeletal proteins (4, 40) . In fact, somewhat overlapping functions of a7b1 integrin and a-dystroglycan are indicated by the finding that the a7 chain is up-regulated in dystrophin-deficient muscles (41, 42) and in those with little or no dystroglycan (43) . Moreover, transgenic overexpression of a7b1 integrin relieves many of the dystrophic symptoms in mice which have a combined loss of dystrophin-and utrophin-associated proteins (44) .
Despite the presence of the DPC, a7-deficient MTJs seem to lack a functional laminin receptor, as suggested by the aberrant deposition of laminin into the matrix of the tendon (34) . Moreover, the retraction of myofilaments (34) suggests an impairment of the cytoplasmic part of mutant MTJs. Our results, showing that a5b1D integrin persists at a7 À/À junctions, point to a selective pressure to retain the b1D chain at this site. In addition to being enriched at regions of force transmission in muscle (15, 17) , b1D is able to enhance the adhesive qualities of transfected non-muscle cells by strengthening the interaction with cytoskeletal and extracellular ligands (19) . However, mice depleted of their b1D-encoding exon show no apparent skeletal muscle defect (21) , whereas a7-deficiency leads to muscle damage precisely at the MTJs. Thus, the combined qualities of a7 and b1D seem to be required at the junctional sarcolemma, not only to provide a Figure 4 . Association between b1D and a5 integrins in a7-deficient skeletal muscles. In a7-deficient muscles, b1D integrin was coimmunoprecipitated by the a5 antibody (upper panel) and vice versa (lower two panels). There was no apparent difference in the a5 signals using extracts from either soleus or TA muscles. The a5 chain precipitated from wild-type extracts was not associated with b1D integrin. As control (c), 20 mg total protein from lung extracts was loaded. laminin receptor but also to displace the connection between a5b1D and fibronectin from the postnatally maturing MTJ.
The switching of extracellular matrix receptors is likely to effect the formation and/or maintenance of the MTJ. By means of mechanotransduction (45) , the a5b1D and a7b1D integrins may transmit specific signals to the inside of the muscle fibre, thereby activating or deactivating signalling pathways and modulating the assembly of the junctional cytoskeleton. In cell culture, the ligands for both receptors are known to have antagonistic effects on muscle, with laminin promoting myogenesis and fibronectin inhibiting differentiation (46) (47) (48) (49) . Given our results that the physiological integrin switch occurs toward the end of secondary myogenesis in mice and that myogenesis is unimpaired in the mutants, the establishment of the a7b1D/laminin connection appears to be particularly important for the maturing MTJ. It may be that only this link Figure 5 . Colocalization of a5 and b1D integrins in a7-deficient muscles. Cryosections of wild-type and mutant TA or soleus muscles were double-labelled with the a5 and b1D antibodies. Extensive colocalization of both immunoreactivities was detected at a7 À/À MTJs (arrows heads) and at the sarcolemma of some mutant soleus fibres. In wild-type muscles, a5 signals were confined to blood vessels and to the connective tissue of the endomysium. Asterisk indicates the tendon in the TA muscle. Bars, 50 mm.
ensures the correct anchoring of junctional myofilaments in the differentiated and contracting muscle. Evidence for this conclusion is provided by our previous observation that the sarcomer had retracted from mutant MTJs (33), suggesting a reduced force transmission from the muscle to the tendon when a7b1 is absent. Further physiological studies, however, will be needed to support our hypothesis.
The precise mechanism by which a5b1D integrin is downregulated from the MTJ is unknown. As we detected declining levels of a5 messenger RNA in postnatal wild-type and mutant muscles, but elevated amounts of a5 protein at adult a7 mutant MTJs, the expression of the a5 chain may be regulated in a complex way. Recent studies revealed that cross-talk between integrins can mediate their functional activation or deactivation. For example, overexpression of a7 integrin in CHO cells interferes with their adherence to fibronectin and the assembly of a fibronectin matrix, apparently by functionally inactivating endogenous the a5b1 integrin (50). Similarly, a3b1 is able to inhibit the function of a2b1 in mammary carcinoma cells and of other integrins in keratinocytes (51, 52) . Conversely, a5 integrin-mediated signalling has been shown to positively influence the binding of a4-containing integrins to fibronectin (53) . According to this evidence, the absent down-regulation of a5b1D at a7-deficient MTJs may be due to the lack of a negative cooperative effect that is usually exerted by the a7 chain. An important question to address next is whether a5b1D and a7b1D integrins are present in an active conformation when they are coexpressed in postnatal muscles.
Additional clues as to whether cross-talk between a5b1D and a7b1D mediates the down-regulation of a5b1D may come Figure 6 . Down-regulation of a5b1D integrin from normal postnatal MTJs. (A) Cryosections of mouse hind limbs were double-labelled with a5 (left panels) and b1D or a7B antibodies (right panels). At P2, wild-type muscles showed extensive colocalization of a5, a7B and b1D at the fibre circumference and at the MTJs. At P10, a5 signals were abundantly detected at intramuscular blood vessels but not at MTJs. In mutant P10 muscles, a5 immunoreactivity persisted at the MTJ and colocalized with b1D integrin. Bar, 100 mm. (B) extracts prepared from P2 and P10 wild-type or a7 À/À muscles were immunoprecipitated with the antibodies indicated on the top of the panels, and analysed by immunoblotting using a5 and a7B antibodies. At P2, the a5 chain was coimmunoprecipitated with b1A and b1D from wild-type and mutant muscles. At P10, little a5 coprecipitated with b1D from wild-type muscles, while mutants displayed strong a5-reactive bands in the b1D precipitates. In control experiments, a7B was immunoprecipitated from wild-type muscles using b1A and b1D antibodies. from proteins that bind to the a5 and a7 subunits. Nischarin, a protein that can interfere with the activity of the Rac GTPase, associates with the cytoplasmic part of a5 (54) . Two other proteins, TIP-2/GIPC and DRAL/FHL2, bind to a5 or a7, respectively (55) (56) (57) . These latter proteins may act as molecular adapters for other proteins since TIP-2/GIPC contains a PDZ domain (a motif first described in PSD-95, Dlg and ZO-1) and because DRAL/FHL2 is a member of the LIM domain protein family. For example, signalling complexes associated with a7 integrin contain p130 CAS /Crk, focal adhesion kinase and paxillin (58) . Future studies will reveal which of these and other protein interactions take place in situ, and whether signalling-mediated receptor cross-talk indeed governs the integrin switch we have reported here.
Unlike integrin a5-deficiency, which also leads to muscle wasting in mice (59), murine a7-deficiency serves as a model for the corresponding human muscle wasting disorder (35, 36) . It is therefore particularly important to decipher the molecular mechanisms underpinning this disease. The loss of the main laminin receptor from a7-deficient muscles is likely to hamper the mechanical stability of the MTJ and to lead to muscle wasting. Yet, a more complex pathogenesis may result from the defective integrin switch we have reported here. The presence of a5b1D may lead to an abnormally increased deposition of fibronectin at mutant MTJ. In turn, fibronectin may trigger signals inside the muscle fibre that form a cytoskeleton/matrix link, which may be insufficient for contracting muscle. In this case, impaired bi-directional signalling at the MTJ would lie at the core of a7-deficiency.
In conclusion, we propose that the defective integrin switch and the assembly of a fibronectin-based matrix is a molecular abnormality that precedes the onset of muscle wasting in a7-deficient mice and possibly patients.
MATERIALS AND METHODS
Isolation of muscle fibres and morphological assessment
Muscle fibres were isolated from 15-week-old wild-type or a7-deficient or mdx mice by dissecting the interosseus muscles of the foot and dissociating them enzymatically for 2 h at 37 C in 1.5 mg/ml collagenase (Serva) and 2 mg/ml neutral protease type IX (Sigma). For each type of animals, two independent preparations generated six cultures. Dissociated fibres were maintained on plastic Petri dishes at 37 C and 5% CO 2 in Ham's F-12 medium supplemented with 10% horse serum. After 2 days, knock-out and control fibres were classified into three groups according to their morphology under phase contrast microscopy: (1) normal fibres with smooth extremities;
(2) mildly damaged fibres showing irregular tips and vacuoles; and (3) fibres displaying grossly irregular tips and large vacuoles (tip diameter with 2-fold the size of the fibre diameter).
Antibody production
The following peptides were synthesised, coupled to maleimide-activated keyhole limpet hemocyanin according to the supplier's protocol (Pierce), and injected into rabbits: a3A, NH 2 -GCRTRALYEAKRQKAEMKSQPSETERLTDDY; a5, NH 2 -GCKRSLPYGTAMEKAQLKPPATSDA; a6A, NH 2 -GCKKDHYDATYHKAEIHAQPSDKERLTSDA; a7A, NH 2 -GCGWDSSSGRSTPRPPSPSTTQ; av, NH 2 -GCKRVRPPQE-EQERE; b1A, NH 2 -GCGENPIYKSAVTTVVNPKYEGK; b1D, NH 2 -IYKSPINNFKNPNYGRKAGLCG. All antibodies were affinity-purified on columns using immobilized BSAcoupled peptides and tested for specificity on normal tissues by immunoblotting and indirect immunofluorescence. The antiintegrin a7B antibody has been characterized (42) . The antiintegrin a5 monoclonal antibody was purchased from BD/Pharmingen, the anti-fibronectin polyclonal antibody was obtained from Gibco/BRL. The anti-integrin a6 monoclonal antibody (GOH3) was a gift of Dr A. Sonnenberg (The Netherlands Cancer Institute). Horseradish peroxidase-coupled secondary antibodies were purchased from Biorad, and fluorophore-conjugated secondary antibodies from Jackson Laboratories.
Histological analysis
For immunofluorescence analysis, freshly prepared muscle tissue was frozen in liquid nitrogen-cooled isopentane, sectioned at 8 mm in the transverse plane, and collected onto TESPA-coated glass slides. The sections were fixed in 1% paraformaldehyde for 10 min at room temperature, followed by methanol fixation for 8 min at À20 C. Thereafter, all incubations were performed at room temperature. The sections were rehydrated and blocked in PBS supplemented with 0.1% (v/v) Tween-20 and 5% normal goat serum for 1 h. This was followed by incubation with the primary antibodies (5 mg/ml, diluted in PBS plus 2% normal goat serum) for 1 h in a humidified chamber. After three washes with PBS, the sections were incubated with Cy2 or Cy3-conjugated secondary antibodies for 30 min, again washed with PBS, and mounted in gelvatol containing 1.5% (w/v) 1,4-diazabicyclo (2.2.2) octane (DABCO, Sigma). For microscopic analysis, we used an Axiophot microscope (Zeiss) and digital recording of the images. Hematoxilin and eosin staining was performed according to standard procedures.
Immunoprecipitation and immunoblotting analysis
Extracts of pooled mouse muscles were prepared by homogenizing freshly dissected tissue in a modified RIPA buffer [50 mM Tris, pH 7.4, 150 mM NaCl, 2.5 mM MgCl 2 , 1% (v/v) Nonidet-P40, 0.05% (v/v) Triton X-100, 0.5% (w/v) Na-deoxycholate, 2.5 mM EDTA, 5 mM N-ethylmaleimide, 2 mM PMSF]. Immunoprecipitation analysis was performed as described (60) . Briefly, 800 mg of pre-cleared RIPA-soluble protein were incubated with 5 mg of affinity-purified antibodies for 2 h at 4 C on a rotating platform. Immune complexes were captured by adding 50 ml of equilibrated Protein A Sepharose CL-4B (Amersham/Pharmacia) and an overnight incubation at 4 C on a rotating platform. After extensive washing in RIPA buffer and once in PBS, immunoprecipitated proteins were eluted from Protein A Sepharose by boiling in SDS/urea buffer [4 M urea, 3.8% SDS, 20% (v/v) glycerol, 75 mM Tris, pH 6.8, 5% (v/v) 2-mercaptoethanol]. Equal volumes of eluted proteins were separated by gradient (5-20%) SDS-PAGE, transferred onto Immobilon-P membranes (Millipore), and detected with antibodies using standard methods. The antibodies against the respective integrin chains were used at 1 mg/ml, and the horseradish peroxidase-conjugated anti-rabbit IgG at 1:10 000 dilution. Protein bands were visualized with ECL (Amersham/ Pharmacia).
Immunogold-histochemistry
Soleus and tibialis anterior (TA) muscles were dissected from 6-week-and 6-month-old mice and immediately fixed for 30 min at 4 C in buffered 4% paraformaldehyde and 0.5% glutaraldehyde. After immersion for 45 min at 4 C in 10 mM ammonium chloride and dehydration in a graded series of ethanol, the specimens were embedded in the acrylic resin LR-Gold (London Resin Company). The resin was hardened at À25 C with the addition of 0.8% benzil and the light of a halogen lamp. Ultrathin sections were cut with a Reichert's ultramicrotome and collected on formvar-coated nickel grids. All ensuing incubations were performed at room temperature (34) . Section-containing grids were blocked for 15 min in PBS containing 1% (w/v) BSA, followed by incubating the primary antibodies (used at 5 mg/ml) for 1 h. After washing in PBS, gold-labelled secondary antibodies (Medac) were applied for 20 min, and again washed in PBS. Finally, the grids were rinsed in water and contrasted. Controls for unspecific binding were Figure 8 . Ultrastructural distribution of a5 and b1D and fibronectin at the normal and a7-deficient MTJ. Ultrathin sections prepared from six month-old wild-type or a7 À/À soleus muscles were labelled with the following antibodies: a5 (A), b1D (B), and fibronectin (C and D). The regions of the MTJs are shown. The a5 and b1D subunits were detected at the plasma membrane of mutant muscles (A, B), while only b1D but not a5 was present in wild-type (A, B, insets). b1D was also abundantly present in the cytoplasm of mutant muscles (B). Fibronectin staining was found in the connective tissue of the wild-types (C). By contrast, at a7 À/À MTJs fibronectin signals were detected at the basement membrane of the muscle fibre (D). The inset in D shows a higher magnification image of the same section. Bars, 0.25 mm; in the insets, (0.30 mm).
performed by incubation with un-coated colloidal gold probes, and by using normal rabbit and rat antisera instead of the primary antibodies. For quantification of gold particles, tissue samples of three homozygous mutant and three control mice were taken and gold particles in a total of 30 randomly selected fields of 4 mm 2 counted for each genotype. Figure 9 . Absence of a5b1D from dystrophin-deficient MTJs. (A) Distribution of the a5 and b1D chains on cryosections of mdx TA muscles. a5 immunoreactivity was observed in the fibrotic areas, but there was little overlapping staining with b1D (Merge). Bar, 50 mm. (B) protein extracts prepared from mdx TA muscles were immunoprecipitated using the b1D antibody and immunoblotted under reducing conditions. Only a7B, but not a5 integrin, was detected in the b1D precipitates. The molecular weight in kDa is shown on the left.
